Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
European Journal of Endocrinology|October 7, 2010
A novel TMEM127 mutation in a patient with familial bilateral pheochromocytomaNelly Burnichon, Charlotte Lepoutre-Lussey, Julien Laffaire, et al.
Blood|February 7, 2004
VEGF-mediated endothelial P-selectin translocation: role of VEGF receptors and endogenous PAF synthesisSimon Rollin, Caroline Lemieux, Ricardo Maliba, et al.
Human Molecular Genetics|October 1, 2005
Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditionsJean-Jacques Brière, Judith Favier, Paule Bénit, et al.
European Journal of Human Genetics : EJHG|January 8, 2026
Insights from 2057 germline genetic tests in renal cell carcinoma patients support revisiting testing criteriaRoseline Vibert, Yahya El Baroudi, Maude Vecten, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2021
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1Aurélien Morini, Tom Drossart, Marc-Olivier Timsit, et al.
British Journal of Haematology|January 10, 2024
EPAS1-mutated paragangliomas associated with haemoglobin disordersMaxence Mancini, Alexandre Buffet, Baptiste Porte, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2012
Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutationsCéline Loriot, Nelly Burnichon, Noémie Gadessaud, et al.
Endocrine Pathology|December 21, 2011
Rationale for anti-angiogenic therapy in pheochromocytoma and paragangliomaJudith Favier, Peter Igaz, Nelly Burnichon, et al.
Science Signaling|March 9, 2017
Dosage-dependent regulation of <i>VAV2</i> expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasionCarmen Ruggiero, Mabrouka Doghman-Bouguerra, Silviu Sbiera, et al.
Pageof 11